PRELUDE CAPITAL MANAGEMENT, LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 162 filers reported holding THERAPEUTICSMD INC in Q4 2020. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2021$4,000
-71.4%
11,000
+6.8%
0.00%
Q1 2021$14,000
+1300.0%
10,300
+1371.4%
0.00%
Q3 2020$1,0000.0%7000.0%0.00%
Q2 2020$1,000
-66.7%
700
-50.7%
0.00%
Q4 2019$3,000
-50.0%
1,421
-9.9%
0.00%
Q3 2019$6,000
+50.0%
1,577
-2.7%
0.00%
Q2 2019$4,000
+300.0%
1,620
+639.7%
0.00%
Q4 2018$1,000
-96.4%
219
-91.9%
0.00%
-100.0%
Q4 2015$28,000
-92.3%
2,700
-96.1%
0.00%
-93.3%
Q4 2013$365,00070,0000.06%
Other shareholders
THERAPEUTICSMD INC shareholders Q4 2020
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 4,115,116$4,979,0001.13%
GMT CAPITAL CORP 5,986,062$7,243,0000.52%
Rubric Capital Management LP 4,520,610$5,470,0000.40%
Handelsinvest Investeringsforvaltning 1,200,000$1,446,0000.22%
RA Capital Management 7,812,500$9,453,0000.13%
Knights of Columbus Asset Advisors LLC 705,105$853,0000.09%
GSA CAPITAL PARTNERS LLP 385,106$466,0000.08%
C WorldWide Group Holding A/S 6,189,834$7,490,0000.08%
Virtu Financial LLC 568,171$687,0000.07%
Aristides Capital LLC 156,747$190,0000.06%
View complete list of THERAPEUTICSMD INC shareholders